Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy

Title
Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 23, Issue 4, Pages 705-709
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-03-06
DOI
10.1097/igc.0b013e31828b1699

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started